Centro Hospitalar Do Tamega E Sousa E.P.E.
- Address
- Avenida Do Hospital Padre Americo 210, 4560-136 Guilhufe, Portugal
Iron Management in Chronic Heart Failure
The cardiology team at Centro Hospitalar Do Tamega E Sousa E.P.E. is evaluating how correcting iron deficiency influences cardiovascular mortality and the rate of hospitalizations for worsening chronic heart failure. The goal is to determine whether intravenous iron can improve outcomes for patients with symptomatic disease.
- Impact of intravenous iron on heart failure outcomes
- Safety profile of ferric derisomaltose in cardiac patients
- Relationship between iron status and cardiovascular events
This research supports the hospital’s commitment to advancing treatment options for patients with combined cardiac and metabolic disorders.
Anti‑inflammatory Approach for Atherosclerotic Disease
Investigators are testing the potential of ziltivekimab, a monthly subcutaneous agent, to lower the risk of MACE in individuals with established ASCVD, chronic kidney disease and systemic inflammation. The study aims to show superiority over placebo when added to standard cardiovascular care.
- Role of inflammation in atherosclerosis progression
- Efficacy of monthly anti‑inflammatory therapy
- Integration of new treatment with existing standard of care
Conducted in Guilhufe, Portugal, this trial reflects the site’s focus on innovative strategies to reduce cardiovascular risk in high‑risk populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pharmacosmos A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 84 other sites in Portugal
Therapeutic Area Benchmark — Portugal
Select a therapeutic area to compare against other sites in Portugal.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Portugal
Market Share
Country: Portugal
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro Hospitalar Do Tamega E Sousa E.P.E.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Cohort study of human mpox virus disease | University Of Oxford | Phase III | Not Recruiting | Aug 2022 | Jan 2024 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ziltivekimab | 2 | Unknown | 2021-09-24 | 2023-05-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.